首页 > 最新文献

Acta Gastroenterologica Latinoamericana最新文献

英文 中文
Endoscopic Findings in Candidate Patients for Bariatric Surgery. 减肥手术候选患者的内镜检查结果。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.360
Nicolás Airaldi, Manuel García, Agustín R Gigena, Fernando Martínez Lascano, Carlos M Esquivel

Introduction: . Obesity is a risk factor for gastrointestinal diseases such as gastroesophageal reflux disease, erosive esophagitis, and hiatal hernia, among others. The presence of some of these diseases during the preoperative bariatric study may condition the surgical technique to be performed.

Materials and methods: . We conducted a retrospective, descriptive, cross-sectional study from a prospectively collected database of patients with obesity treated with bariatric surgery between January 2016 and June 2022 who systematically underwent preoperative upper gastrointestinal endoscopy.

Results: . We evaluated 704 patients who were candidates for bariatric surgery. The mean age of the patients was 40 years, predominantly female (71.6%). The most frequent endoscopic findings were gastropathies, which appeared in 98.9% (n: 696) of the patients, followed by esophageal disorders in 11.6% (n: 82). The prevalence of erosive esophagitis was 9.8% (n: 69). In adittion, 19.7% of the endoscopic findings required preoperative medical treatment and in 4% of the patients the surgical decision was determined by the endoscopic finding.

Conclusion: . Given the high relationship between obesity and diseases of the upper digestive tract, and the interference that these diseases can have in the postoperative evolution of a bariatric patient, we consider that upper gastrointestinal endoscopy should be routinely included in the preparation of the patient who is a candidate for bariatric surgery.

作品简介:。肥胖是胃肠道疾病的危险因素,如胃食管反流病、糜烂性食管炎和裂孔疝等。在术前减肥研究中,其中一些疾病的存在可能会影响手术技术的实施。材料与方法:。我们对2016年1月至2022年6月期间接受减肥手术治疗的肥胖患者进行了回顾性、描述性、横断面研究,这些患者术前系统接受了上消化道内窥镜检查。结果:。我们评估了704名接受减肥手术的患者。患者平均年龄40岁,以女性为主(71.6%)。最常见的内镜检查结果是胃病,98.9% (n: 696)的患者出现胃病,其次是食道疾病,11.6% (n: 82)。糜烂性食管炎的患病率为9.8%(69例)。此外,19.7%的内窥镜检查结果需要术前治疗,4%的患者根据内窥镜检查结果决定手术。结论:。鉴于肥胖与上消化道疾病之间的高度相关性,以及这些疾病对肥胖患者术后发展的干扰,我们认为上消化道内窥镜检查应常规纳入减肥手术候选患者的准备工作中。
{"title":"Endoscopic Findings in Candidate Patients for Bariatric Surgery.","authors":"Nicolás Airaldi, Manuel García, Agustín R Gigena, Fernando Martínez Lascano, Carlos M Esquivel","doi":"10.52787/agl.v53i4.360","DOIUrl":"10.52787/agl.v53i4.360","url":null,"abstract":"<p><strong>Introduction: </strong>. Obesity is a risk factor for gastrointestinal diseases such as gastroesophageal reflux disease, erosive esophagitis, and hiatal hernia, among others. The presence of some of these diseases during the preoperative bariatric study may condition the surgical technique to be performed.</p><p><strong>Materials and methods: </strong>. We conducted a retrospective, descriptive, cross-sectional study from a prospectively collected database of patients with obesity treated with bariatric surgery between January 2016 and June 2022 who systematically underwent preoperative upper gastrointestinal endoscopy.</p><p><strong>Results: </strong>. We evaluated 704 patients who were candidates for bariatric surgery. The mean age of the patients was 40 years, predominantly female (71.6%). The most frequent endoscopic findings were gastropathies, which appeared in 98.9% (n: 696) of the patients, followed by esophageal disorders in 11.6% (n: 82). The prevalence of erosive esophagitis was 9.8% (n: 69). In adittion, 19.7% of the endoscopic findings required preoperative medical treatment and in 4% of the patients the surgical decision was determined by the endoscopic finding.</p><p><strong>Conclusion: </strong>. Given the high relationship between obesity and diseases of the upper digestive tract, and the interference that these diseases can have in the postoperative evolution of a bariatric patient, we consider that upper gastrointestinal endoscopy should be routinely included in the preparation of the patient who is a candidate for bariatric surgery.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"361-368"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500192/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Divertículo esofágico inusual en un paciente anciano. 老年患者不寻常的食道憩室。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.368
Laura Juliana Jaime Ardila, Jorge Carmelo Martínez, Juan Sebastián Frías Ordoñez, Carlos Mauricio Martínez, Oscar Fernando Ruiz Morales, Martín Alonso Gómez Zuleta
{"title":"Divertículo esofágico inusual en un paciente anciano.","authors":"Laura Juliana Jaime Ardila, Jorge Carmelo Martínez, Juan Sebastián Frías Ordoñez, Carlos Mauricio Martínez, Oscar Fernando Ruiz Morales, Martín Alonso Gómez Zuleta","doi":"10.52787/agl.v53i4.368","DOIUrl":"10.52787/agl.v53i4.368","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"346"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Experience in the Use of Tofacitinib in the Treatment of Ulcerative Colitis in Two Pediatric Patients: Two Case Reports]. [托法替尼治疗2例小儿溃疡性结肠炎的经验:2例报告]。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.331
Karen Velásquez Vanegas, Carlos Augusto Cuadros Mendoza, María José Daniels García, Viviana Parra Izquierdo

Introduction: . In this report, the experience using tofacitinib in two pediatric patients diagnosed with ulcerative colitis at the International Hospital of Colombia is described. A review of the current state of the art is also carried out.

Cases: . Both patients had already undergone conventional management without an adequate response for almost two years. In case 1, clinical remission was achieved one month after initiating sustained treatment with tofacitinib. In case 2, clinical and endoscopic remissions were achieved two months after initiating treatment.

Discussion: . Studies have demonstrated its efficacy as induction and maintenance therapy for moderate to severe active ulcerative colitis, with an acceptable safety profile. However, information about the use of tofacitinib within the treatment arsenal is limited in the pediatric age group.

Conclusion: . Tofacitinib is a promising alternative for the treatment of ulcerative colitis with no response or loss of response to conventional treatment. We present the experience of two adolescent patients in whom clinical remission of the disease was achieved earlier than expected, also documenting endoscopic and histologic remission in one of them.

作品简介:。在本报告中,描述了在哥伦比亚国际医院诊断为溃疡性结肠炎的两名儿科患者使用托法替尼的经验。对目前的技术状况也进行了回顾。例:。这两名患者已经接受了常规治疗,但没有足够的反应近两年。在病例1中,临床缓解是在开始持续使用托法替尼治疗一个月后实现的。在病例2中,临床和内镜缓解在开始治疗两个月后实现。讨论:。研究表明其作为诱导和维持治疗中度至重度活动性溃疡性结肠炎的疗效,具有可接受的安全性。然而,关于托法替尼在治疗库中使用的信息在儿科年龄组是有限的。结论:。托法替尼是治疗溃疡性结肠炎的一个很有前途的选择,对常规治疗没有反应或失去反应。我们提出了两名青少年患者的经验,其中临床缓解的疾病比预期的要早,也记录了内窥镜和组织学上的缓解。
{"title":"[Experience in the Use of Tofacitinib in the Treatment of Ulcerative Colitis in Two Pediatric Patients: Two Case Reports].","authors":"Karen Velásquez Vanegas, Carlos Augusto Cuadros Mendoza, María José Daniels García, Viviana Parra Izquierdo","doi":"10.52787/agl.v53i4.331","DOIUrl":"10.52787/agl.v53i4.331","url":null,"abstract":"<p><strong>Introduction: </strong>. In this report, the experience using tofacitinib in two pediatric patients diagnosed with ulcerative colitis at the International Hospital of Colombia is described. A review of the current state of the art is also carried out.</p><p><strong>Cases: </strong>. Both patients had already undergone conventional management without an adequate response for almost two years. In case 1, clinical remission was achieved one month after initiating sustained treatment with tofacitinib. In case 2, clinical and endoscopic remissions were achieved two months after initiating treatment.</p><p><strong>Discussion: </strong>. Studies have demonstrated its efficacy as induction and maintenance therapy for moderate to severe active ulcerative colitis, with an acceptable safety profile. However, information about the use of tofacitinib within the treatment arsenal is limited in the pediatric age group.</p><p><strong>Conclusion: </strong>. Tofacitinib is a promising alternative for the treatment of ulcerative colitis with no response or loss of response to conventional treatment. We present the experience of two adolescent patients in whom clinical remission of the disease was achieved earlier than expected, also documenting endoscopic and histologic remission in one of them.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"395-400"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Von Meyenburg Complexes or Biliary Hamartomas: A Case Report]. [Von Meyenburg复合体或胆道错构瘤1例]。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.323
Rosángela Ramírez Barranco, Carmen Yanette Suárez Quintero, Fredy Ávila Almanza

Introduction: . Von Meyenburg complexes or biliary hamartomas are a rare benign congenital anomaly of the intrahepatic bile ducts. They are usually asymptomatic and incidentally found on imaging studies but can cause jaundice, abdominal pain, and cholangitis.

Case report: . An 80-year-old male patient was admitted to the emergency department due to progressive jaundice associated with pruritus, with an altered hepatogram and a cholestasis pattern. Imaging studies were performed in which there were no alterations in the liver parenchyma or bile ducts. A liver biopsy was performed, which revealed perivenular canalicular cholestasis and the presence of von Meyenburg complexes. The patient was treated with ursodeoxycholic acid with normalization of cholestasis at outpatient follow-up.

Conclusion: . The diagnosis of biliary hamartomas should be considered in patients with intrahepatic cholestasis in whom the etiology is not identified by initial studies. They represent a diagnostic challenge as they are not always seen in imaging studies.

作品简介:。Von Meyenburg复合体或胆道错构瘤是一种罕见的肝内胆管良性先天性异常。它们通常无症状,在影像学检查中偶然发现,但可引起黄疸、腹痛和胆管炎。病例报告:。一名80岁男性患者因进行性黄疸伴瘙痒,肝图改变及胆汁淤积模式入院急诊科。影像学检查显示肝实质或胆管未见改变。肝活检显示静脉周围小管胆汁淤积和von Meyenburg复合物的存在。患者接受熊去氧胆酸治疗,门诊随访时胆汁淤积恢复正常。结论:。胆道错构瘤的诊断应考虑肝内胆汁淤积症患者,其病因未被初步研究确定。它们代表了诊断的挑战,因为它们并不总是在影像学研究中被发现。
{"title":"[Von Meyenburg Complexes or Biliary Hamartomas: A Case Report].","authors":"Rosángela Ramírez Barranco, Carmen Yanette Suárez Quintero, Fredy Ávila Almanza","doi":"10.52787/agl.v53i4.323","DOIUrl":"10.52787/agl.v53i4.323","url":null,"abstract":"<p><strong>Introduction: </strong>. Von Meyenburg complexes or biliary hamartomas are a rare benign congenital anomaly of the intrahepatic bile ducts. They are usually asymptomatic and incidentally found on imaging studies but can cause jaundice, abdominal pain, and cholangitis.</p><p><strong>Case report: </strong>. An 80-year-old male patient was admitted to the emergency department due to progressive jaundice associated with pruritus, with an altered hepatogram and a cholestasis pattern. Imaging studies were performed in which there were no alterations in the liver parenchyma or bile ducts. A liver biopsy was performed, which revealed perivenular canalicular cholestasis and the presence of von Meyenburg complexes. The patient was treated with ursodeoxycholic acid with normalization of cholestasis at outpatient follow-up.</p><p><strong>Conclusion: </strong>. The diagnosis of biliary hamartomas should be considered in patients with intrahepatic cholestasis in whom the etiology is not identified by initial studies. They represent a diagnostic challenge as they are not always seen in imaging studies.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"390-394"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Retrospective Study: Comparison of AIMS65, Rockall and Glasgow Blatchford Scores for Upper Gastrointestinal Bleeding]. [回顾性研究:AIMS65、Rockall和Glasgow Blatchford评分对上消化道出血的比较]。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.371
Virgilio Alvarado Gallo, Jimmy Arias Crespo, María Cepeda Mullo, Silvia Campoverde Duchitanga, Víctor Vera Gordillo, Jorge López Pinto, Rita Pico Rodríguez, Paúl Chamba Molina

Introduction: Upper gastrointestinal bleeding constitutes a primary emergency for emergency services world wide. It has varied etiology and broadther apeutics, so the use of prognostic scalesis necessary to establish the patient's risk.

Objectives: . Determine which of the four scales studied has a greater capacity to discriminate between cases of low and high risk for rebleeding, need for blood transfusion and death.

Materials and methods: . A retrospective cohort study was carried out using the data base of the Guasmo Sur General Hospital from 2020 to 2022, comparing scores obtained by applying the scales to patients diagnosed with upper gastrointestinal bleeding and the irevolution to know their potential prognosis.

Results: . In predicting mortality, the following had better AUC: pre-endoscopic Rockall and AIMS65 with 0.701 and 0.689, respectively; the most useful are Rockall and pre-endoscopic Rockall with sensitivity 95% and NPV 98.3%, with cut-off points of 4 and 3, respectively. In predicting rebleeding, the score with the best AUC was GBS with 0.700, at a cut-off point of 9, it had a sensitivity of 92.3% and a NPV of 95.1%. In predicting the need for transfusion, the one with the best AUC was GBS with 0.766, and a cut-off point of 5, it is the most useful with sensitivity 97.1% and NPV 82.6%.

Conclusion: . The most useful scales for the different outcomes measured were Rockall, pre-endoscopic Rockall and GBS.

上消化道出血是世界范围内急诊服务的主要急症。它具有多种病因和广泛的治疗方法,因此使用预后量表来确定患者的风险是必要的。目的:。确定所研究的四个量表中哪一个更有能力区分再出血、需要输血和死亡的低风险和高风险病例。材料与方法:。采用2020 - 2022年Guasmo Sur总医院数据库进行回顾性队列研究,比较应用该量表对诊断为上消化道出血患者和irevolution患者的评分,了解其潜在预后。结果:。在预测死亡率方面,以下AUC较好:内镜前的Rockall和AIMS65分别为0.701和0.689;最有用的是Rockall和内镜前Rockall,其灵敏度为95%,NPV为98.3%,分界点分别为4和3。在预测再出血时,最佳AUC评分为GBS,为0.700,在截断点为9时,其敏感性为92.3%,NPV为95.1%。在预测是否需要输血时,AUC最好的是GBS,为0.766,截断点为5,最有用的敏感性为97.1%,NPV为82.6%。结论:。测量不同结果最有用的量表是Rockall,内镜前Rockall和GBS。
{"title":"[Retrospective Study: Comparison of AIMS65, Rockall and Glasgow Blatchford Scores for Upper Gastrointestinal Bleeding].","authors":"Virgilio Alvarado Gallo, Jimmy Arias Crespo, María Cepeda Mullo, Silvia Campoverde Duchitanga, Víctor Vera Gordillo, Jorge López Pinto, Rita Pico Rodríguez, Paúl Chamba Molina","doi":"10.52787/agl.v53i4.371","DOIUrl":"10.52787/agl.v53i4.371","url":null,"abstract":"<p><strong>Introduction: </strong>Upper gastrointestinal bleeding constitutes a primary emergency for emergency services world wide. It has varied etiology and broadther apeutics, so the use of prognostic scalesis necessary to establish the patient's risk.</p><p><strong>Objectives: </strong>. Determine which of the four scales studied has a greater capacity to discriminate between cases of low and high risk for rebleeding, need for blood transfusion and death.</p><p><strong>Materials and methods: </strong>. A retrospective cohort study was carried out using the data base of the Guasmo Sur General Hospital from 2020 to 2022, comparing scores obtained by applying the scales to patients diagnosed with upper gastrointestinal bleeding and the irevolution to know their potential prognosis.</p><p><strong>Results: </strong>. In predicting mortality, the following had better AUC: pre-endoscopic Rockall and AIMS65 with 0.701 and 0.689, respectively; the most useful are Rockall and pre-endoscopic Rockall with sensitivity 95% and NPV 98.3%, with cut-off points of 4 and 3, respectively. In predicting rebleeding, the score with the best AUC was GBS with 0.700, at a cut-off point of 9, it had a sensitivity of 92.3% and a NPV of 95.1%. In predicting the need for transfusion, the one with the best AUC was GBS with 0.766, and a cut-off point of 5, it is the most useful with sensitivity 97.1% and NPV 82.6%.</p><p><strong>Conclusion: </strong>. The most useful scales for the different outcomes measured were Rockall, pre-endoscopic Rockall and GBS.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"369-377"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Simultaneous Measurement of Hydrogen and Methane Improves Diagnostic Yield in the Diagnosis of Intestinal Microbial Overgrowth]. [同时测定氢气和甲烷可提高肠道微生物过度生长的诊断率]。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.320
Luis Soifer, Fernando Man, Melina Man

Introduction. Breath tests have been widely used for the diagnosis of small intestinal microbial overgrowth. Some of the equipment currently used for gas measurement tends to have limitations; the simplest portable equipment measures only hydrogen, while the most complete ones allow the simultaneous measurement of hydrogen, methane, CO2, and recently hydrogen sulfide. The presence of elevated methane values usually coincides with decreased hydrogen excretion and, therefore, by measuring only exhaled hydrogen levels, the study is reported erroneously as normal.

Aim: . To analyze the comparative diagnostic yield between the isolated measurement of hydrogen and the simultaneous measurement of hydrogen and methane.

Material and methods: . An observational study was carried out by analyzing hydrogen and methane concentrations in exhaled air, using lactulose as substrate. The study included 353 patients (78% women), with an age range of 18/75, who presented one or more of the following symptoms: abdominal pain, bloating, flatulence and chronic defecatory problems. Values ≥ 20 ppm for hydrogen within 90 minutes lactulose of ingestion were considered positive, and for methane, values ≥ 10 ppm at any time during the study. The diagnostic yield was calculated using the formula: number of positive studies divided by the total number of studies performed. Based on the normal reference values, the number and percentage of diagnoses of small intestinal bacterial overgrowth, intestinal methanogenic overgrowth and mixed microbial overgrowth were calculated.

Results: . Out of a total of 353 patients, 111 (31.44%) were LBT positive; 78 (22.09%) had mixed flora (SIBO + IMO); 54 (15.29%) had methanogenic overgrowth; 55 (15.62%) had small intestine bacterial overgrowth, (accepted as a positive hydrogenic response exclusively) and 55 (15.62%) were negative. Fifty-four (15.29%) had a flat curve. The diagnostic yield varies if we consider only positive SIBO by exclusive hydrogen measurement, in such cases it was 0.16 (95% CI 0.12-0.19). However, when considering mixed cases (partial diagnosis) the diagnostic yield was 0.47 (95% CI 0.41-0.52). On the other hand, the simultaneous measurement of hydrogen and methane added was positive for those with methanogenic overgrowth (111+55+78/353) and the diagnostic yield is 0.69 (CI 0.64-0.73). Conclusion. The simultaneous measurement of H2 and CH4 would improve the diagnostic yield compared to the isolated measurement of hydrogen.

介绍。呼吸试验已被广泛用于诊断小肠微生物过度生长。目前用于气体测量的一些设备往往有局限性;最简单的便携式设备只能测量氢,而最完整的设备可以同时测量氢、甲烷、二氧化碳和最近的硫化氢。甲烷值升高通常与氢气排泄减少同时发生,因此,仅通过测量呼出的氢气水平,该研究被错误地报告为正常。目的:。分析氢气分离测定和氢气甲烷同时测定的诊断率比较。材料和方法:。以乳果糖为底物,通过分析呼出空气中的氢和甲烷浓度进行了一项观察性研究。该研究包括353名患者(78%为女性),年龄范围为18/75岁,表现出以下一种或多种症状:腹痛、腹胀、胀气和慢性排便问题。在摄入乳果糖90分钟内,氢气浓度≥20ppm为阳性,甲烷浓度≥10ppm为阳性。诊断率的计算公式为:阳性研究数除以进行的研究总数。在正常参考值的基础上,计算小肠细菌过度生长、肠道产甲烷过度生长和混合微生物过度生长的诊断率和百分比。结果:。353例患者中,111例(31.44%)为LBT阳性;混合菌群(SIBO + IMO) 78株(22.09%);54株(15.29%)产甲烷过度生长;小肠细菌过度生长55例(15.62%),为纯氢反应阳性,阴性55例(15.62%)。54例(15.29%)呈平坦曲线。如果我们只考虑通过单独的氢测量SIBO阳性,则诊断率会有所不同,在这种情况下,诊断率为0.16 (95% CI 0.12-0.19)。然而,当考虑混合病例(部分诊断)时,诊断率为0.47 (95% CI 0.41-0.52)。另一方面,产甲烷过度生长菌同时测定氢气和甲烷含量为阳性(111+55+78/353),诊断产率为0.69 (CI 0.64-0.73)。结论。与单独测定氢气相比,同时测定H2和CH4可提高诊断产率。
{"title":"[Simultaneous Measurement of Hydrogen and Methane Improves Diagnostic Yield in the Diagnosis of Intestinal Microbial Overgrowth].","authors":"Luis Soifer, Fernando Man, Melina Man","doi":"10.52787/agl.v53i4.320","DOIUrl":"10.52787/agl.v53i4.320","url":null,"abstract":"<p><p><b>Introduction</b>. Breath tests have been widely used for the diagnosis of small intestinal microbial overgrowth. Some of the equipment currently used for gas measurement tends to have limitations; the simplest portable equipment measures only hydrogen, while the most complete ones allow the simultaneous measurement of hydrogen, methane, CO2, and recently hydrogen sulfide. The presence of elevated methane values usually coincides with decreased hydrogen excretion and, therefore, by measuring only exhaled hydrogen levels, the study is reported erroneously as normal.</p><p><strong>Aim: </strong>. To analyze the comparative diagnostic yield between the isolated measurement of hydrogen and the simultaneous measurement of hydrogen and methane.</p><p><strong>Material and methods: </strong>. An observational study was carried out by analyzing hydrogen and methane concentrations in exhaled air, using lactulose as substrate. The study included 353 patients (78% women), with an age range of 18/75, who presented one or more of the following symptoms: abdominal pain, bloating, flatulence and chronic defecatory problems. Values ≥ 20 ppm for hydrogen within 90 minutes lactulose of ingestion were considered positive, and for methane, values ≥ 10 ppm at any time during the study. The diagnostic yield was calculated using the formula: number of positive studies divided by the total number of studies performed. Based on the normal reference values, the number and percentage of diagnoses of small intestinal bacterial overgrowth, intestinal methanogenic overgrowth and mixed microbial overgrowth were calculated.</p><p><strong>Results: </strong>. Out of a total of 353 patients, 111 (31.44%) were LBT positive; 78 (22.09%) had mixed flora (SIBO + IMO); 54 (15.29%) had methanogenic overgrowth; 55 (15.62%) had small intestine bacterial overgrowth, (accepted as a positive hydrogenic response exclusively) and 55 (15.62%) were negative. Fifty-four (15.29%) had a flat curve. The diagnostic yield varies if we consider only positive SIBO by exclusive hydrogen measurement, in such cases it was 0.16 (95% CI 0.12-0.19). However, when considering mixed cases (partial diagnosis) the diagnostic yield was 0.47 (95% CI 0.41-0.52). On the other hand, the simultaneous measurement of hydrogen and methane added was positive for those with methanogenic overgrowth (111+55+78/353) and the diagnostic yield is 0.69 (CI 0.64-0.73). Conclusion. The simultaneous measurement of H2 and CH4 would improve the diagnostic yield compared to the isolated measurement of hydrogen.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"378-384"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[[Introduction to the Analysis of Recurrent Events in Clinical Trials]]. [临床试验中复发事件分析简介]。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.365
Emiliano Rossi
{"title":"[[Introduction to the Analysis of Recurrent Events in Clinical Trials]].","authors":"Emiliano Rossi","doi":"10.52787/agl.v53i4.365","DOIUrl":"10.52787/agl.v53i4.365","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"331-333"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500180/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Allergy to Cow's Milk Protein Simulating Hirschsprung's Disease Based on Barium Enema Findings. A Case Report]. 基于钡灌肠结果的牛奶蛋白过敏模拟先天性巨结肠病病例报告]。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.318
Juanita Higuera Carrillo, Michelle Higuera

Introduction: . Cow's milk protein allergy can have multiple clinical manifestations. Some cases present with inflammation of the rectosigmoid colon with secondary colonic dysmotility similar to Hirschsprung's disease. Previous studies have shown that the proportion of cow's milk protein allergy in newborns presenting with Hirschsprung's disease-like symptoms is high.

Aim: . To describe the clinical case of a patient with cow's milk protein allergy, with symptoms and barium enema imaging suggestive of Hirschsprung's disease.

Clinical case: . A term infant, previously healthy, with episodes of regurgitation since two weeks of life and worsening of symptoms with vomiting and irritability at three months of age. Physical examination revealed findings compatible with cow's milk protein allergy. She was exclusively breastfed and instructed to continue on a cow's milk exclusion diet. Three days after the onset of symptoms, her condition worsened with vomiting and the imaging studies were expanded with findings that could have been related to Hirschsprung's Disease. An endorectal biopsy was performed and Hirschsprung's disease was ruled out. It was indicated to discontinue breastfeeding and continue with the amino acid-based formula, with adequate tolerance, weight and height progression, resolution of xeroderma and abdominal distension.

Conclusion: . In patients with severe abdominal distension or findings simulating Hirschsprung's disease, cow's milk protein allergy should be considered as an increasingly common entity in the differential diagnosis, and appropriate diagnostic tests should be performed to establish the diagnosis. Endorectal biopsy is indicated to confirm the definitive diagnosis of Hirschsprung's disease.

作品简介:。牛奶蛋白过敏可有多种临床表现。有些病例表现为直肠乙状结肠炎症伴继发性结肠运动障碍,类似于先天性巨结肠病。先前的研究表明,在新生儿中,牛奶蛋白过敏的比例很高,表现出先天性巨结肠的疾病样症状。目的:。描述一例牛奶蛋白过敏患者的临床病例,其症状和钡灌肠成像提示先天性巨结肠病。临床病例:。足月婴儿,既往健康,自出生两周起出现反胃发作,3个月时出现呕吐和烦躁症状加重。体检结果与牛奶蛋白过敏相符。她被完全母乳喂养,并被指示继续吃不含牛奶的饮食。症状出现三天后,她的病情因呕吐而恶化,影像学检查扩大了可能与先天性巨结肠病有关的发现。进行了直肠内活检,排除了先天性巨结肠的疾病。建议停止母乳喂养,继续以氨基酸为基础的配方,有足够的耐受性,体重和身高的进展,干皮病和腹胀的解决。结论:。在严重腹胀或类似巨结肠病的患者中,牛奶蛋白过敏应被视为鉴别诊断中越来越常见的因素,并应进行适当的诊断检查以确定诊断。直肠内活检可明确诊断巨结肠病。
{"title":"[Allergy to Cow's Milk Protein Simulating Hirschsprung's Disease Based on Barium Enema Findings. A Case Report].","authors":"Juanita Higuera Carrillo, Michelle Higuera","doi":"10.52787/agl.v53i4.318","DOIUrl":"10.52787/agl.v53i4.318","url":null,"abstract":"<p><strong>Introduction: </strong>. Cow's milk protein allergy can have multiple clinical manifestations. Some cases present with inflammation of the rectosigmoid colon with secondary colonic dysmotility similar to Hirschsprung's disease. Previous studies have shown that the proportion of cow's milk protein allergy in newborns presenting with Hirschsprung's disease-like symptoms is high.</p><p><strong>Aim: </strong>. To describe the clinical case of a patient with cow's milk protein allergy, with symptoms and barium enema imaging suggestive of Hirschsprung's disease.</p><p><strong>Clinical case: </strong>. A term infant, previously healthy, with episodes of regurgitation since two weeks of life and worsening of symptoms with vomiting and irritability at three months of age. Physical examination revealed findings compatible with cow's milk protein allergy. She was exclusively breastfed and instructed to continue on a cow's milk exclusion diet. Three days after the onset of symptoms, her condition worsened with vomiting and the imaging studies were expanded with findings that could have been related to Hirschsprung's Disease. An endorectal biopsy was performed and Hirschsprung's disease was ruled out. It was indicated to discontinue breastfeeding and continue with the amino acid-based formula, with adequate tolerance, weight and height progression, resolution of xeroderma and abdominal distension.</p><p><strong>Conclusion: </strong>. In patients with severe abdominal distension or findings simulating Hirschsprung's disease, cow's milk protein allergy should be considered as an increasingly common entity in the differential diagnosis, and appropriate diagnostic tests should be performed to establish the diagnosis. Endorectal biopsy is indicated to confirm the definitive diagnosis of Hirschsprung's disease.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"385-389"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500188/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment of Fecal Incontinence: A Surgical Approach]. [治疗大便失禁:手术方法]。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.375
Alejandro Moreira Grecco, Tomás Flores

A review of the different treatments for fecal incontinence is presented, with special emphasis on the results of surgical procedures for this condition. It addresses a comprehensive and personalized approach to the management of patients with fecal incontinence, which is of capital importance, where the results of the different therapeutic options must be weighed in their relationship to the quality of life of the patients. Finally, a treatment algorithm for said condition is suggested.

回顾了大便失禁的不同治疗方法,特别强调了这种情况的外科手术的结果。它解决了一个全面的和个性化的方法来管理患者的大便失禁,这是至关重要的,其中不同的治疗方案的结果必须在他们的关系,以患者的生活质量进行权衡。最后,提出了一种针对上述情况的治疗算法。
{"title":"[Treatment of Fecal Incontinence: A Surgical Approach].","authors":"Alejandro Moreira Grecco, Tomás Flores","doi":"10.52787/agl.v53i4.375","DOIUrl":"10.52787/agl.v53i4.375","url":null,"abstract":"<p><p>A review of the different treatments for fecal incontinence is presented, with special emphasis on the results of surgical procedures for this condition. It addresses a comprehensive and personalized approach to the management of patients with fecal incontinence, which is of capital importance, where the results of the different therapeutic options must be weighed in their relationship to the quality of life of the patients. Finally, a treatment algorithm for said condition is suggested.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"337-345"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Screening for Biliary Atresia through QR Code Implementation]. 【通过二维码筛查胆道闭锁】。
Q4 Medicine Pub Date : 2023-12-29 eCollection Date: 2023-10-01 DOI: 10.52787/agl.v53i4.338
Cinthia Bastianelli, Adriana Spiess, Analía Gallardo, Estefanía Bracamonte, Emanuel Campos, Margarita Ramonet

Introduction: . Biliary atresia is an inflammatory, obstructive, and idiopathic process affecting the bile ducts that leads to biliary cirrhosis. Early diagnosis and Kasai surgery offer patients the possibility of survival without requiring a liver transplant.

Main: . To describe the implementation of a novel method of screening for biliary atresia using a quick response (QR) code at a fourth-level care hospital.

Materials and methods: . An observational, descriptive and prospective study was carried out at the Hospital Público Materno Infantil, Salta, Argentina, between September 2022 and September 2023. During this period, the screening for biliary atresia was carried out through a survey accessible via a QR code. This survey had to be completed between 15-30 days of life of the newborn´s, comparing the color of stools with a numbered colorimetric chart. The responses were categorized as "normal" and "abnormal". Patients with abnormally colored stools were contacted by phone and scheduled for a medical consultation.

Results: . A total of 6,113 live newborns were registered. 1,294 surveys were analyzed. The response rate was 21%. 57.3% of respondents completed the survey between 15 and 30 days after birth. Among the 1,294 patients surveyed, 17 recorded abnormal responses, of which one had biliary atresia and two had secondary cholestasis. The screening presented a false-positive rate of 1.1% (14/1,294). The estimated percentage of true positives from the screening was 0.2% (3/1,294). The prevalence of biliary atresia was 0.1% (1/1,294).

Conclusion: . The response rate to screening for biliary atresia using the QR code during the evaluated period was lower than that reported using colorimetric cards. Adherence increased in the last months of the program´s implementation, which requires more time for execution and dissemination. We believe that this technological innovation applied to screening could represent a progress in the early detection of biliary atresia.

作品简介:。胆道闭锁是一种影响胆管的炎性、梗阻性和特发性过程,可导致胆汁性肝硬化。早期诊断和Kasai手术为患者提供了不需要肝移植而存活的可能性。主要:。目的描述在一家四级护理医院使用快速反应(QR)码筛查胆道闭锁的新方法的实施。材料与方法:。2022年9月至2023年9月,在阿根廷萨尔塔Público母婴医院进行了一项观察性、描述性和前瞻性研究。在此期间,通过QR码进行调查,对胆道闭锁进行筛查。该调查必须在新生儿出生后15-30天完成,通过编号比色图比较粪便的颜色。调查结果分为“正常”和“异常”两类。通过电话联系大便颜色异常的患者,并安排进行医疗咨询。结果:。共登记新生儿6113例。分析了1294份调查。回复率为21%。57.3%的受访者在出生后15至30天内完成调查。在1294例患者中,17例出现异常反应,其中1例为胆道闭锁,2例为继发性胆汁淤积。假阳性率为1.1%(14/ 1294)。筛查的真阳性估计百分比为0.2%(3/1,294)。胆道闭锁患病率为0.1%(1/ 1294)。结论:。在评估期间,使用QR码筛查胆道闭锁的应答率低于使用比色卡的应答率。在该计划实施的最后几个月,依从性有所提高,这需要更多的时间来执行和传播。我们相信,这项技术创新应用于筛查可以代表一个进步,在早期发现胆道闭锁。
{"title":"[Screening for Biliary Atresia through QR Code Implementation].","authors":"Cinthia Bastianelli, Adriana Spiess, Analía Gallardo, Estefanía Bracamonte, Emanuel Campos, Margarita Ramonet","doi":"10.52787/agl.v53i4.338","DOIUrl":"10.52787/agl.v53i4.338","url":null,"abstract":"<p><strong>Introduction: </strong>. Biliary atresia is an inflammatory, obstructive, and idiopathic process affecting the bile ducts that leads to biliary cirrhosis. Early diagnosis and Kasai surgery offer patients the possibility of survival without requiring a liver transplant.</p><p><strong>Main: </strong>. To describe the implementation of a novel method of screening for biliary atresia using a quick response (QR) code at a fourth-level care hospital.</p><p><strong>Materials and methods: </strong>. An observational, descriptive and prospective study was carried out at the Hospital Público Materno Infantil, Salta, Argentina, between September 2022 and September 2023. During this period, the screening for biliary atresia was carried out through a survey accessible via a QR code. This survey had to be completed between 15-30 days of life of the newborn´s, comparing the color of stools with a numbered colorimetric chart. The responses were categorized as \"normal\" and \"abnormal\". Patients with abnormally colored stools were contacted by phone and scheduled for a medical consultation.</p><p><strong>Results: </strong>. A total of 6,113 live newborns were registered. 1,294 surveys were analyzed. The response rate was 21%. 57.3% of respondents completed the survey between 15 and 30 days after birth. Among the 1,294 patients surveyed, 17 recorded abnormal responses, of which one had biliary atresia and two had secondary cholestasis. The screening presented a false-positive rate of 1.1% (14/1,294). The estimated percentage of true positives from the screening was 0.2% (3/1,294). The prevalence of biliary atresia was 0.1% (1/1,294).</p><p><strong>Conclusion: </strong>. The response rate to screening for biliary atresia using the QR code during the evaluated period was lower than that reported using colorimetric cards. Adherence increased in the last months of the program´s implementation, which requires more time for execution and dissemination. We believe that this technological innovation applied to screening could represent a progress in the early detection of biliary atresia.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 4","pages":"355-360"},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Gastroenterologica Latinoamericana
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1